Image courtesy of Sapheneia
January 7, 2015 — Less than 30 days after the Sapheneia Scannerside partnership announcement, the two companies released CMS Lung Screening, ClearCT Lung.
On November 10, 2014, the U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening for Medicare recipients. Part of the radiology imaging center eligibility criteria include Low Dose Computed Tomography (LDCT) of less than 1.5 mSv and the collection and submission of data to a CMS-approved national registry. ClearCT Lung provides an affordable solution for radiology imaging centers to meet these criteria.
For more information: www.Sapheneia.com, www.Scannerside.com
March 25, 2026 
